SCHEMBL23488472

SCHEMBL23488472

CO[C@@H]1O[C@H](COC(=O)c2cc(OCc3ccccc3)ccc2C)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.43
LGALS8 O00214 1/20 0.42
SLC5A2 P31639 3/20 0.42
SLC5A1 P13866 2/20 0.42
MEN1 O00255 1/20 0.42
HSP90AA1 P07900 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
TYMP P19971 1/20 0.41
NMT1 P30419 4/20 0.40
NMT2 O60551 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
S1PR1 P21453 1/20 0.38
S1PR5 Q9H228 1/20 0.38
CA9 Q16790 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488464 0.92 MAOB (0.43) MAOBLGALS8SLC5A2SLC5A1MEN1
SCHEMBL23488550 0.92 MAOB (0.43) MAOBLGALS8SLC5A2SLC5A1MEN1
SCHEMBL23488152 0.88 MAOB (0.44) MAOBMEN1HSP90AA1KMT2ATDP1
SCHEMBL23488593 0.88 MAOB (0.44) MAOBMEN1HSP90AA1KMT2ATDP1
SCHEMBL23488274 0.88 TDP1 (0.49) MAOBLGALS8SLC5A2SLC5A1MEN1
SCHEMBL23488256 0.87 MAOB (0.41) MAOBSLC5A2SLC5A1MEN1HSP90AA1
SCHEMBL23488257 0.87 MAOB (0.40) MAOBSLC5A2SLC5A1MEN1HSP90AA1
SCHEMBL23488128 0.85 CHRNB2 (0.51) MAOBLGALS8SLC5A2SLC5A1TDP1
SCHEMBL23488262 0.85 CHRNB2 (0.51) MAOBLGALS8SLC5A2SLC5A1TDP1
SCHEMBL23488668 0.85 CHRNB2 (0.51) MAOBLGALS8SLC5A2SLC5A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 MAOB 4123/4885LGALS8 61/4885SLC5A2 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.